Location: Home
  • search
  • go
  • Relate News
  • 3/26/2025Life Science Ecosystems in Asia: Biomedical Innovation Trends over the...
  • 3/25/2025Anda Biopharma Secures Series A Funding to Advance PCNAT-01 Clinical S...
  • 3/25/2025Novo Nordisk and the United Labs Announce License Deal for UBT251
  • 3/25/2025BrightGene Initiates Phase II Head-to-Head Study of AI-Designed BGM050...
  • 3/25/2025Everest Announces FDA Clearance of IND Application for Tumor-Associate...
  • 3/25/2025Eli Lilly Launches Lilly Gateway Laboratory in Beijing to Foster Innov...
  • 3/25/2025Merck Group to Expand in China with Focus on AI-Powered Precision Medi...
  • 3/25/2025China's BMI Fund Surpasses CNY16.5 Trillion with 11% Annual Growth
  • 3/25/2025Expedition Therapeutics Secures Seed Funding to Bridge Chinese Innovat...
  • 3/25/2025Growing Awareness and Expanding Treatment Options for Sleep Disorders ...
  • 3/25/2025Hengrui and Elevar Face Second FDA Rejection for Liver Cancer Combo Th...
  • 3/24/2025Elevation Oncology to Discontinue Development of CSPC-licensed EO-3021
  • 3/24/2025HBM Enters into Global Strategic Deal with AstraZeneca for Next-Gen Th...
  • 3/24/2025AstraZeneca Announces $2.5B Investment in China
  • 3/24/2025Syneron Bio Announces Strategic Collaboration with AstraZeneca
  • 3/24/2025GenScript's RA Drug Candidate Receives FDA Clearance for Clinical Tria...
  • 3/24/2025SineuGene's SNUG01 Gene Therapy Receives FDA IND Approval for ALS Clin...
  • 3/24/2025FDA Rejects HLB Group's Liver Cancer Drug, Highlighting Regulatory and...
  • 3/24/2025CDE Seeks Public Comments on Draft ICH M11 Clinical Protocol Template
  • 3/24/2025China Sets Ambitious Nutritional Targets for 2030 to Improve National ...
  • 3/24/2025Heng Ren Partners Calls for $8.9B Cash Distribution from Sinovac and ...
  • 3/21/2025Forward Pharma Secures CNY 100M Financing
  • 3/21/2025Innovent and Hutchmed's FRUSICA-2 Study Achieves Primary Endpoint
  • 3/21/2025Dizal's Golidocitinib in Combo with Anti-PD-1 Shows Promise in IO Resi...
  • 3/21/2025Rhythm Pharma Regains Rights to Obesity Drug in China
  • 3/21/2025Henlius' HER2-Targeting Antibody HLX22 Granted FDA Orphan Drug Designa...
  • 3/21/2025CDE Solicits Comments on Chinese Translation of ICH E6 (R3) GCP Guidel...
  • 3/21/2025Hengrui's Ivarmacitinib Secures First Approval in China for Ankylosing...
  • 3/21/2025NHC Vice-Minister Meets with CEO of Belgian Biopharma Firm UCB
  • 3/21/2025NHSA Releases Its 2024 Statistical Bulletin on Healthcare Security De...
  • Page:7/764 Total number of articles:22894: [First][<<] [5] [6] [7] [8] [9] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group